2022-11-16
Ginkgo Bioworks said after the close of the market on Monday that it has raised its full-year 2022 revenue guidance to between $460 million and $480 million, up from previous guidance of between $425 million and $440 million, driven by strength in the firm's biosecurity business.... Read More >